# US 2016/0253454 A1 · Method of evaluating female genital cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0253454 A1
- Document ID: US20160253454A1
- Status: Published application
- Kind: A1
- Application number: 14/988,986
- Filed: 2016-01-06
- Published: 2016-09-01
- Earliest claimed: 2008-06-20
- Assignees: Ajinomoto Co., Inc.
- Applicants: Ajinomoto Co., Inc.
- Inventors: Takahiko MURAMATSU; Yutaka IHATA; Akira IMAIZUMI; Hiroshi YAMAMOTO; Etsuko MIYAGI; Fumiki HIRAHARA
- Web page: https://patentgrep.com/patent/US20160253454A1

## CPC

- G16B 40/20: Supervised data analysis
- G01N 33/57545: of the ovaries
- G01N 33/5755: of the uterine cervix, uterine corpus or endometrium
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

According to the method of evaluating female genital cancer of the present invention, amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated is measured, and the state of female genital cancer including at least one of cervical cancer, endometrial cancer, and ovarian cancer in the subject is evaluated based on the concentration value of at least one of Thr, Ser, Asn, Gln, Pro, Gly, Ala, Cit, Val, Met, Ile, Leu, Tyr, Phe, His, Trp, Orn, Lys, and Arg contained in the measured amino acid concentration data of the subject.

## Claims

### Claim at position 1

-19. (canceled)

### Claim 20

A method of evaluating female genital cancer, comprising:
a discriminant value calculating step of calculating a discriminant value that is a value of a multivariate discriminant containing concentration of an amino acid as an explanatory variable, by a central processing unit (CPU) executing a female genital cancer-evaluating program stored on a computer-readable recoding medium and configured to calculate the discriminant value, based on both (i) the concentration value of at least one or more of Asn, Cit, Gln, Pro, Ser, Thr, Trp, and Met in blood of a subject to be evaluated and (ii) the multivariate discriminant for evaluating a state of female genital cancer comprising at least one of cervical cancer, endometrial cancer, and ovarian cancer,
wherein the multivariate discriminant contains the at least one or more of Asn, Cit, Gln, Pro, Ser, Thr, Trp, and Met as the explanatory variable,
wherein the female genital cancer-evaluating program provides instructions to the CPU to generate the discriminant value in which the risk of female genital cancer is reflected.

### Claim 21 (depends on 20)

The method of evaluating female genital cancer according to claim 20, wherein the multivariate discriminant contains three or more amino acids as the explanatory variables, wherein the three or more amino acids includes the at least one or more of Asn, Cit, Gln, Pro, Ser, Thr, Trp, and Met.

### Claim 22 (depends on 21)

The method of evaluating female genital cancer according to claim 21, wherein the three or more amino acids includes the at least one or more of Asn, Cit, Gln, Pro, Ser, Thr, Ser, Thr, Trp, and Met and at least one or more of His, Val, Ile, Gly, Leu, Phe, Tyr, Arg, Ala, Lys, Orn and ABA.
